Presented ByProf. Pierfranco Conte, University of Padova, Italy
TrialPhase 3, A-BRAVE ConferenceASCO 2024
TypePeer-reviewed article
18 July 2024 14:53
Presented ByDr Erica Mayer (Dana-Farber Cancer Institute, MA, USA); Prof. Virginia Kaklamani (University of Texas Health Sciences Center, TX, USA);
TrialPACE; EMERALD; SERENA-2; CAPItello-291; VERITAC ConferenceSABCS 2022
TypePeer-reviewed article
1 February 2023 18:03
Presented ByProf. Julien Taieb, Hopital European George Pompidou, France
TrialPhase 2, SAMCO-PRODIGE 54 ConferenceESMO 2022
TypePeer-reviewed article
16 November 2022 17:13
Presented ByDr Roberto Iacovelli, Catholic University of Rome, Italy
TrialPhase 2, ARIES ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:17
Presented ByDr Axel Bex, Netherlands Cancer Institute, the Netherlands
TrialPhase 2, NeoAvAx ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:14
Presented ByDr Rachel Giles, Medicom
ConferenceASCO GU 2022
14 March 2022 07:21
ConferenceESMO 2020
TypePeer-reviewed article
25 November 2020 15:13
ConferenceESMO 2020
TypePeer-reviewed article
25 November 2020 14:41
ExpertDr Sophie Cousin, Institut Bergonié, France
TrialPhase 1/2, REGOMUNE ConferenceASCO 2020
TypePeer-reviewed article
17 September 2020 14:52
ExpertProf. Thomas Powles, Barts Cancer Institute, UK
TrialPhase 3, JAVELIN Bladder 100 ConferenceASCO 2020
17 September 2020 14:30
ExpertProf. Benoit You, Lyon University Hospital, France
TrialPhase 2, TROPHIMMUN ConferenceASCO 2020
9 September 2020 14:17
TrialPhase 3, JAVELIN Lung 200 ConferenceWCLC 2018
TypePeer-reviewed article
21 November 2018 22:46
